Stock Events

Stock Events

Tiziana Life Sciences 

$1.3100
42
+$0.08+6.5% Thursday 20:00
+$0.00+0%Thursday 21:24After hours

Statistics

Day High
1.318
Day Low
1.31
52W High
2.6
52W Low
1.04
Volume
972
Avg. Volume
-
Mkt Cap
166.71M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7OctExpected
Q3 2023
Q1 2024
Q3 2024
Q1 2025
Q3 2025
Q1 2026
Next
-0.09
-0.08
-0.07
-0.06
Expected EPS
-0.079184061
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2015
2016
2017
2018
2019
2020
0Revenue
-30.79MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TLSA. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bristol-Myers Squibb
BMY
Mkt Cap117.46B
Bristol Myers Squibb is a global biopharmaceutical company focusing on discovering, developing, and delivering innovative medicines for patients with serious diseases, including areas where Tiziana is active.
Regeneron Pharmaceuticals
REGN
Mkt Cap66.35B
Regeneron Pharmaceuticals is involved in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions, competing directly in the biotech space with Tiziana.
Gilead Sciences
GILD
Mkt Cap158.77B
Gilead Sciences is a biopharmaceutical company that researches, develops, and commercializes drugs in areas overlapping with Tiziana's interests, particularly in oncology and inflammatory diseases.
AMGEN
AMGN
Mkt Cap193.39B
Amgen is a biotechnology pioneer that discovers, develops, manufactures, and delivers innovative human therapeutics, including treatments in areas that Tiziana Life Sciences targets.
Abbvie
ABBV
Mkt Cap447.62B
AbbVie is a research-based biopharmaceutical company with a strong emphasis on research and development in areas similar to Tiziana, such as immunology and oncology.
Merck
MRK
Mkt Cap317.77B
Merck & Co., Inc. is a global healthcare company that operates in the same therapeutic areas as Tiziana, making it a direct competitor in the pharmaceutical and biotech industry.
Pfizer
PFE
Mkt Cap138.44B
Pfizer is a global pharmaceutical corporation with a broad range of products in various therapeutic areas, including those being pursued by Tiziana, making it a competitor.
Novartis
NVS
Mkt Cap296.54B
Novartis is a global healthcare company that engages in the research, development, manufacturing, and marketing of a wide range of healthcare products, directly competing with Tiziana.
Roche
RHHBY
Mkt Cap333.25B
Roche Holding AG is a leader in research-focused healthcare with strengths in pharmaceuticals and diagnostics, competing in the same therapeutic areas as Tiziana.
Astrazeneca
AZN
Mkt Cap292.2B
AstraZeneca is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, including in areas that overlap with Tiziana's focus.

About

Tiziana Life Sciences Ltd is a biotechnology firm dedicated to the research and advancement of novel molecular therapies for human ailments, particularly within oncology and immunology. Its flagship immunology program features Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody under development for a range of conditions including Crohn's disease, graft versus host disease, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel disease, psoriasis, and rheumatoid arthritis. Additionally, the company is progressing Milciclib (TZLS-201), a small molecule inhibitor that targets multiple cyclin-dependent, tropomycin receptor, and Src family kinases to suppress abnormal cell growth and cancer progression. Another significant asset is anti-Interleukin 6 receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody intended to mitigate IL6-induced inflammation and treat COVID-19 patients. Founded in 1998, Tiziana Life Sciences is based in London, United Kingdom.
Show more...
CEO
Mr. Gabriele Marco Antonio Cerrone M.B.A.
Employees
9
Country
United Kingdom
ISIN
BMG889121031

Listings

STU
DE
0RP.STU
F
DE
0RP.F
MU
DE
0RP.MU
XNAS
US
TLSA

0 Comments

Share your thoughts

FAQ

What is Tiziana Life Sciences stock price today?▼
The current price of TLSA is $1.31 USD — it has increased by +6.5% in the past 24 hours. Watch Tiziana Life Sciences stock price performance more closely on the chart.
What is Tiziana Life Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Tiziana Life Sciences stocks are traded under the ticker TLSA.
Is Tiziana Life Sciences stock price growing?▼
TLSA stock has risen by +11.02% compared to the previous week, the month change is a +5.65% rise, over the last year Tiziana Life Sciences has showed a -14.94% decrease.
What is Tiziana Life Sciences market cap?▼
Today Tiziana Life Sciences has the market capitalization of 166.71M
When is the next Tiziana Life Sciences earnings date?▼
Tiziana Life Sciences is going to release the next earnings report on October 07, 2026.
What is Tiziana Life Sciences revenue for the last year?▼
Tiziana Life Sciences revenue for the last year amounts to 0 USD.
What is Tiziana Life Sciences net income for the last year?▼
TLSA net income for the last year is -30.79M USD.
How many employees does Tiziana Life Sciences have?▼
As of July 05, 2026, the company has 9 employees.
In which sector is Tiziana Life Sciences located?▼
Tiziana Life Sciences operates in the Health & Wellness sector.
When did Tiziana Life Sciences complete a stock split?▼
The last stock split for Tiziana Life Sciences was on July 31, 2020 with a ratio of 2.5:1.
Where is Tiziana Life Sciences headquartered?▼
Tiziana Life Sciences is headquartered in London, United Kingdom.